Blood flow stimulation and reduction of sensory neurotoxicities in cytostatic-induced polyneuropathy


MAGCELL® MICROCIRC can positively influence symptoms of neurotoxicities like sensory ataxia, neuropathy and neuropathic pain symptoms (especially CIPN I-IV) on hands and feet as a result of chemotherapy. Moreover a significant increase in nerve conductivity speed (ulnar nerve) was achieved by the treatment.


  • Electrode-free electrotherapy for therapists and patients
  • Pulsating electromagnetic fields (PEMF)
  • Field strength more than 1000 gauss
  • Effective treatment concept due to repeatable short-treatment periods
  • Through-textile treatment (even through shoes)



Please share this content...


  • Very easy one-button operation
  • Battery-driven
  • Optical and acoustic function control
  • Automatic switch-off at the end of the therapy period
Source: Funk et al. (2014) 
  • 1 Control (without MAGCELL® MICROCIRC)
  • 2 Two minutes after treatment with MAGCELL® MICROCIRC

MAGCELL® MICROCIRC significantly increases micro-circulation (p < 0,001) while nitric oxide (NO) has a blood vessel dilatory effect. The authors recommend the therapy for clinical situations where an improvement in micro circulation is identified, like for instance in the case of chronic tissue repair.

  • 3 and 4 MAGCELL® MICROCIRC electrode free electrotherapy - simple and effective

See also 

MAGCELL® MICROCIRC leads to volume reduction in benign prostate hyperplasia (BPH) in a relatively short time

Therapeutic Use of Pulsed Electromagnetic Field Therapy Reduces Prostate Volume and Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia. Andrology. 2020 Feb 23. doi: 10.1111/andr.12775. [Epub ahead of print] PubMed PMID: 32090492. Tenuta M, Tarsitano MG, Mazzotta P, Lucchini L, Sesti F, Fattorini G, Pozza C, Olivieri V, Naro F, Gianfrilli D, Lenzi A, Isidori AM, Pofi R.

Read on PressReleasePoint 20th March 2020

The treatment (2 x 5 min. daily) resulted in a significant volume reduction of the prostate after only 28 days of therapy (V1) compared to the start of treatment (V0).

That the therapy effect is sustainable is shown by the fact that even after 4 months (V2) there was a significantly reduced prostate volume compared to the start of treatment (V0).

The survey on quality of life (IPSS questionnaire: urination/quality of life) also showed significantly better results at both points in time (V1 and V2) than V0.

Overall, there was a rapid improvement in symptoms without changes in gonadal hormones or sexual function, with high compliance and without side effects.

MAGCELL® MICROCIRC leads to volume reduction in benign prostate hyperplasia (BPH) in a relatively short timeBest results were achieved in moderate to severe symptoms (LUTS) and patients without metabolic syndrome (MetS).


Study in The Prostate - MAGCELL® VETRI

Effect of Pulsed Electromagnetic Field Therapy on Prostate Volume and Vascularity in theTreatment of Benign Prostatic Hyperplasia: A Pilot Study in a Canine Mode which concludes:

"The efficacy of PEMF on BPH in dogs, with no side effects, suggests the suitability of this treatment in humans and supports the hypothesis that impairment of blood supply to the lower urinary tract may be a causative factor in the development of BPH."

  • Protection class: Internal power supply
  • Power supply: 2 x 1.5 V R6 alkaline batteries
  • Magnetic field strength max: 200 mT 
  • Treatment duration MAGCELL® MICROCIRC 5 min. 
  • Dimensions (W x H x D): 83 x 152 x 25 mm 
  • Weight: 0.21 kg
  • [2] Batteries
  • [1] Metal case
  • [1] Operating instructions